Clinical trials
Completed Breast Neoplasms trials in Jordan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| King Hussein Cancer Center | 2 |
| Al-Zaytoonah University of Jordan | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| International Cancer Research Group, United Arab Emirates | 1 |
| Kashiv BioSciences, LLC | 1 |
| Pfizer | 1 |
| Puma Biotechnology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 14 |
| Neoplasm Metastasis | 2 |
| Breast Diseases | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.